Orin Bio: Planning to issue H shares and list on the Hong Kong Stock Exchange.

Oulian Biology announced that the company is planning to issue overseas shares and apply for listing on the Hong Kong Stock Exchange in order to deepen its international strategic layout, enhance its international reputation and influence, further optimize its capital structure, and strengthen its overall competitive strength. Currently, the company is in discussions with relevant intermediaries regarding the details of this H-share listing, which have not yet been determined. The H-share listing work still needs to be submitted to the company's board of directors and shareholders' meeting for review, as well as obtaining filing, approval, or approval from relevant government agencies and regulatory authorities.